News

Following the establishment of the Hangzhou Sanofi Minsheng Consumer Healthcare joint venture, the acquisition of BMP Sunstone will make sanofi-aventis a consumer healthcare company in China, with a

Bristol-Myers Squibb and Otsuka Pharmaceutical are collaborative partners in the commercialisation of Sprycel in the US, Japan and major European countries. Sprycel was discovered and developed by Bristol-Myers

Humira, a fully human anti-TNF monoclonal antibody that exerts its effects by neutralising TNF, is a cytokine that plays a central role in inflammatory responses. Humira is already

The Multi-Source Injectables business comprises a portfolio of 41 products in over 150 dosage strengths and forms across 23 therapeutic areas. The business’ product portfolio also includes several

Lubrizol has posted a net income of $211.8m for the third quarter 2010, or $3.08 per diluted share, compared to $170.5m, or $2.46 per diluted share, for the

North American-based SOHM is a generic pharmaceutical manufacturer that produces and markets generic drugs, covering all major treatment categories. SOHM Corporate Strategy vice president Shailesh Shah said that

Bemis has posted a net income of $61.42m for the third quarter 2010, or $0.56 per diluted share, compared to $35.84m, or $0.33 per diluted share, for the

Prior to Ancora Pharma, Siber worked as the vice president and chief scientific officer of Wyeth. Prior to his work at Wyeth Vaccines Research, Siber was associate professor

Before joining Idenix in 2007, Renaud worked as the senior vice president and chief financial officer of Keryx Biopharmaceuticals. Idenix Pharma lead director of the board of directors